4.8 Article

Protein Microgels from Amyloid Fibril Networks

期刊

ACS NANO
卷 9, 期 1, 页码 43-51

出版社

AMER CHEMICAL SOC
DOI: 10.1021/nn504869d

关键词

microfluidics; protein nanofibrils; microgels; lysozyme; drug release

资金

  1. Elan Pharmaceuticals
  2. BBSRC
  3. Leverhulme Trust
  4. ERC
  5. Frances and Augustus Newman Foundation
  6. Magdalene College, Cambridge
  7. BBSRC [BB/J002119/1] Funding Source: UKRI
  8. Biotechnology and Biological Sciences Research Council [BB/J002119/1] Funding Source: researchfish

向作者/读者索取更多资源

Nanofibrillar forms of proteins were initially recognized in the context of pathology, but more recently have been discovered in a range of functional roles in nature, including as active catalytic scaffolds and bacterial coatings. Here we show that protein nanofibrils can be used to form the basis of monodisperse microgels and gel shells composed of naturally occurring proteins. We explore the potential of these protein microgels to act as drug carrier agents, and demonstrate the controlled release of four different encapsulated drug-like small molecules, as well as the component proteins themselves. Furthermore, we show that protein nanofibril self-assembly can continue after the initial formation of the microgel particles, and that this process results in active materials with network densities that can be modulated in situ. We demonstrate that these materials are nontoxic to human cells and that they can be used to enhance the efficacy of antibiotics relative to delivery in homogeneous solution. Because of the biocompatibility and biodegradability of natural proteins used in the fabrication of the microgels, as well as their ability to control the release of small molecules and biopolymers, protein nanofibril microgels represent a promising class of functional artificial multiscale materials generated from natural building blocks.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据